Related Experiment Video
Updated: Jun 10, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Earlier intervention in the management of hypercholesterolemia: what are we waiting for?
1Department of Medicine, University of California San Diego, La Jolla, California 92093, USA. dsteinberg@ucsd.edu
Abstract:
The thesis advanced here is that we are initiating treatment of hypercholesterolemia (and other risk factors) too late in life. Initiating treatment at, for example, age 30 years instead of age 60 years might very well prevent not just 30% of events, as in the 5-year statin trials, but perhaps as many as 60%.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management
Atherosclerosis IV: Nursing Management
Cholesterol: Significance and Regulation
Considering cholesterol and...